• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾滋病中的消瘦综合征:病理生理机制与治疗方法

Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches.

作者信息

Weinroth S E, Parenti D M, Simon G L

机构信息

Department of Medicine, George Washington University Medical Center, Washington, D.C. 20037, USA.

出版信息

Infect Agents Dis. 1995 Jun;4(2):76-94.

PMID:7613731
Abstract

Wasting syndrome is a common complication of HIV infection and is marked by progressive weight loss and weakness, often associated with fever and diarrhea. The pathophysiologic mechanisms responsible for this syndrome are not well defined, but it is clear that this is a multifactorial process in which the relative contribution of individual etiologic factors vary among patients. Considerations include inadequate diet, malabsorptive phenomena, metabolic derangements, and cytokine activity. The onset of opportunistic infections is often accompanied by a hypermetabolic state characterized by progressive weight loss. Potential cytokines that may promote weight loss in AIDS patients include tumor necrosis factor, interleukin-1, interleukin-6, and alpha-interferon. At present there is no effective treatment. Multiple therapeutic methods, including enteral and parenteral alimentation, appetite stimulants, recombinant growth hormone, and cytokine modulators, are currently being explored.

摘要

消瘦综合征是人类免疫缺陷病毒(HIV)感染的常见并发症,其特征为进行性体重减轻和虚弱,常伴有发热和腹泻。导致该综合征的病理生理机制尚未完全明确,但显然这是一个多因素过程,其中个体病因因素的相对贡献在患者之间有所不同。需要考虑的因素包括饮食不足、吸收不良现象、代谢紊乱和细胞因子活性。机会性感染的发生通常伴随着以进行性体重减轻为特征的高代谢状态。可能促使艾滋病患者体重减轻的潜在细胞因子包括肿瘤坏死因子、白细胞介素-1、白细胞介素-6和α-干扰素。目前尚无有效的治疗方法。目前正在探索多种治疗方法,包括肠内和肠外营养、食欲刺激剂、重组生长激素和细胞因子调节剂。

相似文献

1
Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches.艾滋病中的消瘦综合征:病理生理机制与治疗方法
Infect Agents Dis. 1995 Jun;4(2):76-94.
2
Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation.人类免疫缺陷病毒相关消瘦及与炎症相关的恶病质机制。
Semin Oncol. 1998 Feb;25(1 Suppl 1):73-81.
3
Weight loss and wasting in patients infected with human immunodeficiency virus.感染人类免疫缺陷病毒患者的体重减轻和消瘦
Clin Infect Dis. 2003 Apr 1;36(Suppl 2):S69-78. doi: 10.1086/367561.
4
Wasting in the acquired immunodeficiency syndrome.获得性免疫缺陷综合征中的消瘦
Semin Liver Dis. 1992 May;12(2):175-87. doi: 10.1055/s-2007-1007389.
5
Manaing HIV. Part 5: Treating secondary outcomes. 5.17 HIV, weight loss and wasting syndrome.管理艾滋病毒。第5部分:治疗次要结局。5.17艾滋病毒、体重减轻和消瘦综合征。
Med J Aust. 1996 May 6;164(9):549-50.
6
Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.重组人生长激素在HIV相关消瘦和恶病质中的作用:病理生理学及治疗原理
Clin Ther. 2007 Nov;29(11):2269-88. doi: 10.1016/j.clinthera.2007.11.004.
7
Wasting syndrome--affordable treatments.消瘦综合征——可负担得起的治疗方法。
AIDS Treat News. 1995 Jul 7(no 226):6-7.
8
The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome.人类免疫缺陷病毒与获得性免疫缺陷综合征中消瘦的病因
Semin Oncol. 1998 Apr;25(2 Suppl 6):76-81.
9
Anticytokine approaches to the treatment of anorexia and cachexia.抗细胞因子疗法治疗厌食症和恶病质
Semin Oncol. 1998 Apr;25(2 Suppl 6):53-7.
10
Testosterone replacement, weight lifting help wasting.睾酮替代疗法和举重有助于改善肌肉萎缩。
AIDS Alert. 1996 Jun;11(6):suppl 1-2.

引用本文的文献

1
12-week Dolutegravir treatment marginally reduces energy expenditure but does not increase body weight or alter vascular function in a murine model of Human Immunodeficiency Virus infection.12 周多替拉韦治疗在人类免疫缺陷病毒感染的小鼠模型中轻微降低能量消耗,但不增加体重或改变血管功能。
Vascul Pharmacol. 2024 Jun;155:107288. doi: 10.1016/j.vph.2024.107288. Epub 2024 Feb 28.
2
Tricarboxylic acid (TCA) cycle, sphingolipid, and phosphatidylcholine metabolism are dysregulated in infection-induced cachexia.三羧酸(TCA)循环、鞘脂代谢和磷脂酰胆碱代谢在感染诱导的恶病质中失调。
Heliyon. 2023 Jul 5;9(7):e17411. doi: 10.1016/j.heliyon.2023.e17411. eCollection 2023 Jul.
3
The atherogenic index of plasma as a predictor of mortality in patients with COVID-19.
血浆致动脉粥样硬化指数可预测 COVID-19 患者的死亡率。
Heart Lung. 2021 Mar-Apr;50(2):329-333. doi: 10.1016/j.hrtlng.2021.01.016. Epub 2021 Jan 26.
4
Nutritional status of HIV-positive patients in Niterói, Rio de Janeiro, Brazil.巴西里约热内卢尼泰罗伊市HIV阳性患者的营养状况。
J Health Popul Nutr. 2014 Dec;32(4):595-9.
5
Functional interaction between HIV-gp120 and opioid system in the preoptic anterior hypothalamus.在视前前下丘脑,HIV-gp120 与阿片系统的功能相互作用。
Drug Alcohol Depend. 2014 Jan 1;134:383-386. doi: 10.1016/j.drugalcdep.2013.09.015. Epub 2013 Sep 26.
6
Intrahypothalamic injection of the HIV-1 envelope glycoprotein induces fever via interaction with the chemokine system.下丘脑内注射 HIV-1 包膜糖蛋白通过与趋化因子系统相互作用引起发热。
J Pharmacol Exp Ther. 2010 Feb;332(2):549-53. doi: 10.1124/jpet.109.160309. Epub 2009 Nov 11.
7
Growth and puberty in children with HIV infection.感染艾滋病毒儿童的生长发育与青春期
J Endocrinol Invest. 2009 Jan;32(1):85-90. doi: 10.1007/BF03345686.
8
Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone.用于控制释放人生长激素的聚(D,L-丙交酯-共-乙交酯)微球的制备与表征
AAPS PharmSciTech. 2003;4(2):E28. doi: 10.1208/pt040228.
9
Role of cytokines in AIDS wasting.细胞因子在艾滋病消瘦中的作用。
Nutrition. 1998 Nov-Dec;14(11-12):853-63. doi: 10.1016/s0899-9007(98)00108-7.
10
HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting.人类免疫缺陷病毒糖蛋白120抑制生长激素轴:艾滋病消瘦发病机制中一种可能的生长激素释放激素受体机制。
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1927-32. doi: 10.1073/pnas.95.4.1927.